Cytomegalovirus retinitis in patients with AIDS: current status

About 20%-30% of patients with AIDS will develop cytomegalovirus (CMV) retinitis when they are severely immunodeficient (CD4 cell count below 40 cells/microL). It causes extensive retinal damage with visual deficits, and relapses are frequent. Intravenous ganciclovir and foscarnet are standard thera...

Full description

Saved in:

Bibliographic Details
Published in:	Medical journal of Australia Vol. 163; no. 9; p. 489
Main Author:	Luckie, A P
Format:	Journal Article
Language:	English
Published:	Australia 06-11-1995
Subjects:	AIDS-Related Opportunistic Infections - diagnosis AIDS-Related Opportunistic Infections - drug therapy Antiviral Agents - therapeutic use Cytomegalovirus Retinitis - diagnosis Cytomegalovirus Retinitis - drug therapy Foscarnet - therapeutic use Ganciclovir - therapeutic use Humans
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	About 20%-30% of patients with AIDS will develop cytomegalovirus (CMV) retinitis when they are severely immunodeficient (CD4 cell count below 40 cells/microL). It causes extensive retinal damage with visual deficits, and relapses are frequent. Intravenous ganciclovir and foscarnet are standard therapy, but their high toxicity and long term intravenous access mean that advances in treatment, including oral prophylactic agents, intravitreal injections and surgical implants, may provide a better quality of life for patients. Prophylactic ophthalmological screening of patients with CD4 cell counts below 100 cells/microL to detect asymptomatic retinitis is needed.
ISSN:	0025-729X
DOI:	10.5694/j.1326-5377.1995.tb124699.x